Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L M Jansen

Showing results (91-100 of 150) with videos related to

Pageof 15
Sort By:
Hepatology (Baltimore, Md.)|April 2, 2019
Gallbladder Dyskinesia Is Associated With an Impaired Postprandial Fibroblast Growth Factor 19 Response in Critically Ill PatientsKiran V K Koelfat, Mark P Plummer, Frank G Schaap, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|January 23, 2010
The hepatic response to FGF19 is impaired in patients with nonalcoholic fatty liver disease and insulin resistanceTim C M A Schreuder, Hendrik A Marsman, Martin Lenicek, et al.
Plos One|April 5, 2013
Liver fibrosis in type I Gaucher disease: magnetic resonance imaging, transient elastography and parameters of iron storageAnneloes E Bohte, Laura van Dussen, Erik M Akkerman, et al.
Psychoneuroendocrinology|August 8, 1998
Differential effects of hydrocortisone and dexamethasone on cortisol suppression in a child psychiatric populationC C Gispen-de Wied, L M Jansen, H J Wynne, et al.
Molecular Pharmacology|June 20, 2003
Phenobarbital alters hepatic Mrp2 function by direct and indirect interactionsNita J Patel, Maciej J Zamek-Gliszczynski, Peijin Zhang, et al.
Psychoneuroendocrinology|September 21, 2000
Unresponsiveness to psychosocial stress in a subgroup of autistic-like children, multiple complex developmental disorderL M Jansen, C C Gispen-de Wied, R J Van der Gaag, et al.
Scandinavian Journal of Gastroenterology|July 9, 2008
Inflammatory markers neopterin and alanine aminotransferase in HCV patients treated with HCV NS3.4A protease inhibitor telaprevir (VX-950) and/or peginterferon alfa-2aHuub C Gelderblom, Stefan Zeuzem, Christine J Weegink, et al.
Antiviral Therapy|June 27, 2007
Low-level HCV viraemia after initial response during antiviral therapy: transcription-mediated amplification predicts treatment failureHuub C Gelderblom, Henk W Reesink, Marcel G H M Beld, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 23, 2007
High incidence of type 1 diabetes mellitus during or shortly after treatment with pegylated interferon alpha for chronic hepatitis C virus infectionTim C M A Schreuder, Huub C Gelderblom, Christine J Weegink, et al.
International Journal of Obesity (2005)|January 24, 2014
Gallstone disease in severely obese children participating in a lifestyle intervention program: incidence and risk factorsA Heida, B G P Koot, O H vd Baan-Slootweg, et al.
Pageof 15

Showing results (91-100 of 150) with videos related to

Sort By:
Pageof 15
Hepatology (Baltimore, Md.)|April 2, 2019
Gallbladder Dyskinesia Is Associated With an Impaired Postprandial Fibroblast Growth Factor 19 Response in Critically Ill PatientsKiran V K Koelfat, Mark P Plummer, Frank G Schaap, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|January 23, 2010
The hepatic response to FGF19 is impaired in patients with nonalcoholic fatty liver disease and insulin resistanceTim C M A Schreuder, Hendrik A Marsman, Martin Lenicek, et al.
Plos One|April 5, 2013
Liver fibrosis in type I Gaucher disease: magnetic resonance imaging, transient elastography and parameters of iron storageAnneloes E Bohte, Laura van Dussen, Erik M Akkerman, et al.
Psychoneuroendocrinology|August 8, 1998
Differential effects of hydrocortisone and dexamethasone on cortisol suppression in a child psychiatric populationC C Gispen-de Wied, L M Jansen, H J Wynne, et al.
Molecular Pharmacology|June 20, 2003
Phenobarbital alters hepatic Mrp2 function by direct and indirect interactionsNita J Patel, Maciej J Zamek-Gliszczynski, Peijin Zhang, et al.
Psychoneuroendocrinology|September 21, 2000
Unresponsiveness to psychosocial stress in a subgroup of autistic-like children, multiple complex developmental disorderL M Jansen, C C Gispen-de Wied, R J Van der Gaag, et al.
Scandinavian Journal of Gastroenterology|July 9, 2008
Inflammatory markers neopterin and alanine aminotransferase in HCV patients treated with HCV NS3.4A protease inhibitor telaprevir (VX-950) and/or peginterferon alfa-2aHuub C Gelderblom, Stefan Zeuzem, Christine J Weegink, et al.
Antiviral Therapy|June 27, 2007
Low-level HCV viraemia after initial response during antiviral therapy: transcription-mediated amplification predicts treatment failureHuub C Gelderblom, Henk W Reesink, Marcel G H M Beld, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 23, 2007
High incidence of type 1 diabetes mellitus during or shortly after treatment with pegylated interferon alpha for chronic hepatitis C virus infectionTim C M A Schreuder, Huub C Gelderblom, Christine J Weegink, et al.
International Journal of Obesity (2005)|January 24, 2014
Gallstone disease in severely obese children participating in a lifestyle intervention program: incidence and risk factorsA Heida, B G P Koot, O H vd Baan-Slootweg, et al.
Pageof 15